Medicare billing address
CMS Medicare provider billing file
7908 Bustleton AvePhiladelphia, PA 19152
CMS public data · NPI 1093083552
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Shikha Rathi, MBBS, MD
Specialty
Credential
MBBS, MD
NPI
1093083552
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Shikha Rathi, MBBS, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
7908 Bustleton AveCMS Doctors & Clinicians file
7908 Bustleton AveCMS Doctors & Clinicians file
920 Town Ctr DrIn the 2024 CMS provider billing file, this NPI had 400 Medicare beneficiaries and 98,003 total services. The average beneficiary age was 73, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$1,560,169.69
Total Medicare payment amount
$1,235,340.99
Medicare beneficiaries
400
Total services
98,003
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Osteoporosis
56%
CMS beneficiary-panel share
Ischemic heart disease
30%
CMS beneficiary-panel share
Anxiety
29%
CMS beneficiary-panel share
Diabetes
27%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, tocilizumab, 1 mg | 26,440 | $5.92 |
| Injection, golimumab, 1 mg, for intravenous use | 18,803 | $11.39 |
| Injection, romosozumab-aqqg, 1 mg | 11,131 | $10.76 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,000 | $4.54 |
| Injection, infliximab, excludes biosimilar, 10 mg | 8,962 | $31.38 |
| Injection, denosumab, 1 mg | 7,140 | $25.52 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,526 | $42.68 |
| Injection, methylprednisolone acetate, 1 mg | 1,436 | $0.13 |
| Injection, methylprednisolone sodium succinate, 5 mg | 593 | $0.29 |
| Administration of chemotherapy into vein, 1 hour or less | 375 | $136.90 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1093083552. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 364 | 705.9 | $12,011.38 |
| 2 | Prednisone | Prednisone | 272 | 421.9 | $1,576.98 |
| 3 | Methotrexate | Methotrexate Sodium | 264 | 423.5 | $4,438.45 |
| 4 | Duloxetine Hcl | Duloxetine Hcl | 139 | 264 | $3,215.26 |
| 5 | Methylprednisolone | Methylprednisolone | 92 | 118 | $562.58 |
| 6 | Leflunomide | Leflunomide | 80 | 136 | $3,294.86 |
| 7 | Tizanidine Hcl | Tizanidine Hcl | 75 | 86.8 | $592.41 |
| 8 | Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 73 | 79 | $299.07 |
| 9 | Tramadol Hcl | Tramadol Hcl | 68 | 68 | $436.37 |
| 10 | Allopurinol | Allopurinol | 59 | 105 | $364.70 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2008
Group/practice field
Arthritis Group Pc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Geriatric Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.